Pre Market Game Plan by AJ – 1/9/19

1) $ATOS Reports Positive Final Results from Male Phase 1 Study of Topical Endoxifen (1.23) Stock Gapping up +.50 this could run at open through…

ac tradingJanuary 9, 2019